Metabolomics in Early-Phase Clinical Trials from 2010 to 2025

Jack T. Thompson, Maia Megase, Marta Boffito, Mark J. Caulfield, Emma F. Magavern

Open source

DOI
10.3390/metabo16100777
Published
2026-10-14
Container
Metabolites
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo16100777,
  title = {Metabolomics in Early-Phase Clinical Trials from 2010 to 2025},
  author = {Jack T. Thompson and Maia Megase and Marta Boffito and Mark J. Caulfield and Emma F. Magavern},
  year = {2026},
  journal = {Metabolites},
  doi = {10.3390/metabo16100777},
  url = {https://doi.org/10.3390/metabo16100777}
}

RIS

TY  - JOUR
TI  - Metabolomics in Early-Phase Clinical Trials from 2010 to 2025
AU  - Jack T. Thompson
AU  - Maia Megase
AU  - Marta Boffito
AU  - Mark J. Caulfield
AU  - Emma F. Magavern
PY  - 2026
JO  - Metabolites
DO  - 10.3390/metabo16100777
UR  - https://doi.org/10.3390/metabo16100777
ER  - 

APA

Thompson, J. T., Megase, M., Boffito, M., Caulfield, M. J., & Magavern, E. F. (2026). Metabolomics in Early-Phase Clinical Trials from 2010 to 2025. Metabolites. https://doi.org/10.3390/metabo16100777

Source records